Loading
No insider purchase over the last 90 days. The latest, by Gottlieb Scott, was filed 01 Jun 2009.
Molecular Insight Pharmaceuticals, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Molecular Insight Pharmaceuticals, Inc. The previous disclosure was published on 28 January 2011.
Over the whole record (from 2007), the tally stands at 38 purchases and 57 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
25 of 127 declarations